Microbot Medical Inc (NASDAQ:MBOT) shares reached a new 52-week low on Wednesday . The company traded as low as $5.30 and last traded at $5.44, with a volume of 470 shares trading hands. The stock had previously closed at $5.71.
A number of research analysts recently weighed in on the stock. ValuEngine cut shares of Microbot Medical from a “buy” rating to a “hold” rating in a research note on Tuesday, October 2nd. Zacks Investment Research cut shares of Microbot Medical from a “hold” rating to a “sell” rating in a research note on Friday, September 28th.
Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings results on Tuesday, August 14th. The biotechnology company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). On average, research analysts anticipate that Microbot Medical Inc will post -2.4 earnings per share for the current year.
Microbot Medical Company Profile (NASDAQ:MBOT)
Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.
Read More: What is the NASDAQ Stock Market?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.